Redox Metabolism and Vascular Calcification in Chronic Kidney Disease
Authors:
- Natalia Carrillo-LópezNCNatalia Carrillo-López
- Sara PanizoSPSara Panizo
- Beatriz Martín-CarroBMBeatriz Martín-Carro
- Juan Carlos Mayo BarralloJuan Carlos Mayo Barrallo
- Pablo Román-GarcíaPRPablo Román-García
- Raúl García-CastroRGRaúl García-Castro
- Jesús María Fernández-GómezJFJesús María Fernández-Gómez
- Miguel Ángel Hevia-SuárezMHMiguel Ángel Hevia-Suárez
- Julia Martín-VírgalaJMJulia Martín-Vírgala
- Sara Fernández-VillabrilleSFSara Fernández-Villabrille
- Laura Martínez-AriasLMLaura Martínez-Arias
- Sara Barrio VázquezSVSara Barrio Vázquez
Open Access
- 20 September 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (9) , 1419
Abstract
Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox regulators, such as catalase, the main scavenger of H2O2, remains unclear. In the present study, epigastric arteries of kidney transplant recipients, a rat model of VC, and an in vitro model of VC exhibiting catalase (Cts) overexpression were analysed. Pericalcified areas of human epigastric arteries had increased levels of catalase and cytoplasmic, rather than nuclear runt-related transcription factor 2 (RUNX2). In the rat model, advanced aortic VC concurred with lower levels of the H2O2-scavenger glutathione peroxidase 3 compared to controls. In an early model of calcification using vascular smooth muscle cells (VSMCs), Cts VSMCs showed the expected increase in total levels of RUNX2. However, Cts VMSCs also exhibited a lower percentage of the nucleus stained for RUNX2 in response to calcifying media. In this early model of VC, we did not observe a dysregulation of the mitochondrial redox state; instead, an increase in the general redox state was observed in the cytoplasm. These results highlight the complex role of antioxidant enzymes as catalase by regulation of RUNX2 subcellular location delaying the onset of VC.Keywords
All Related Versions
Funding Information
- Instituto de Salud Carlos III (ISCIII) (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Next Generation EU (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Recovery, Transformation and Resilience Plan (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Recovery, Transformation and Resilience Plan (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Plan Estatal de I+D+I 2013–2016, Plan de Ciencia, Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Gobierno del Principado de Asturias (“Severo Ochoa” program) (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Ministerio de Ciencia, Innovación y Universidades (FPU program) (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
- Kidney Disease (RD12/0021/0023, RD16/0009/0017, RD21/0005/0019, PI11-00667, PI14/00707, PI17/00384, PI20/00633, PI20/00753, PI22/00195, GRUPIN14-028, IDI-2018-000152, IDI/2021/000080, BP19-057, BP20-081, FPU2019-00483, RICORS2040)
This publication has 29 references indexed in Scilit:
- Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC studyJournal of Clinical Biochemistry and Nutrition, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout miceAmerican Journal of Physiology-Renal Physiology, 2011
- Vascular Calcification in Patients with Chronic Kidney Disease: Types, Clinical Impact and PathogenesisMedical Principles and Practice, 2011
- Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2011
- Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT SignalingJournal of Biological Chemistry, 2008
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Association between Chronic Kidney Disease and Coronary Artery CalcificationJournal of the American Society of Nephrology, 2005
- A strategy for the ubiquitous overexpression of human catalase and CuZn superoxide dismutase genes in transgenic miceMechanisms of Ageing and Development, 2003
- New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up studyAtherosclerosis, 1997